Abstract:ABSTRACT Complete identification methods are critical for evaluating nontuberculous mycobacteria (NTM). Here, we describe a novel diagnostic method for identification of eight NTM, Mycobacterium tuberculosis complex, and three drug resistance markers using PCR/matrix-assisted, laser-desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) from cultured organisms. With this technology, a multiplex end-point PCR is performed for targets of interest. Detection probes that are extended in the presence of a target are added. The extended probes have greater molecular weight and can be detected by MALDI-TOF MS. An AFB Primary Panel was designed to differentiate Mycobacterium avium ; Mycobacterium intracellulare subsp. chimaera ; Mycobacterium avium complex (other); Mycobacterium abscessus subsp. abscessus , bolletii , and massiliense ; Mycobacterium kansasii , and M. tuberculosis complex. This design should cover 90% (3,483/3,691) of mycobacteria seen onsite. A development set of unblinded isolates ( n = 217) was used to develop PCR primers, detection probes, and probe barcodes. It demonstrated 99.1% (215/217) agreement with reference methods. An evaluation set using blinded isolates ( n = 320) showed an overall sensitivity of 94.3% (range by target: 90.0–100%). Overall specificity from negative media, non-target mycobacteria, and bacteria was 99.1% (108/109; range by target: 94.4–100%). Three drug resistance markers erm (41), rrl, and rrs demonstrated 100%, 91%, and 100% sensitivity, respectively, and >99% specificity. Limit of detection per target ranged from 2.2 × 10 3 to 9.9 × 10 6 CFU/mL. The AFB Primary Panel allows for mycobacterial speciation, subspeciation, and resistance mutation detection, which is essential for diagnosis, appropriate therapy, identifying outbreaks, and managing treatment-refractory disease. It can perform with high-throughput and high specificity and sensitivity from isolates. IMPORTANCE Even closely related mycobacteria can have unique treatment patterns, but differentiating these organisms is a challenge. Here, we tested an innovative platform that combines two commonly used technologies and creates something new: matrix-assisted, laser-desorption ionization time-of flight mass spectrometry was performed on PCR amplicons instead of on proteins. This created a robust system with the advantages of PCR (high discriminatory power, high throughput, detection of resistance) with the advantages of mass spectrometry (more targets, lower operational cost) in order to identify closely related mycobacterial organisms.

Rapid Differentiation of Haemophilus influenzae and Haemophilus haemolyticus by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry with ClinProTools Mass Spectrum Analysis

Rapid Identification of Common Clinical Organism by Matrix-Assisted Laser Desorption/ionization Time Of-Fright Mass Spectrometry

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for rapid identification of Corynebacterium species of clinical isolates

Simultaneous Detection of Key Bacterial Pathogens Related to Pneumonia and Meningitis Using Multiplex PCR Coupled with Mass Spectrometry.

Expansion of MALDI-TOF MS database as a strategy for identification of Haemophilus species other than H. influenzae

Direct MALDI-TOF MS Identification of Bacterial Mixtures

Clinical Application of Matrix-Assisted Laser-Resolved Ionization Time-Of-Flight Mass Spectrometry for Rapid Detection of Blood-Borne Pathogens.

Rapid identification and classification of Mycobacterium spp. using whole-cell protein barcodes with matrix assisted laser desorption ionization time of flight mass spectrometry in comparison with multigene phylogenetic analysis.

Rapid Identification of Nontuberculous Mycobacterium Using Matrix Assisted Laser Desorption/ionization Time of Flight Mass Spectrometry

Rapid Identification of Methicillin-Resistant Staphylococcus Aureus and Methicillin-Sensitive Staphylo-coccus Aureus Strains by Matrix-Assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry

Rapid differentiation of Staphylococcus aureus subspecies based on MALDI-TOF MS profiles

Matrix-assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry for the Identification of Beta-Hemolytic Streptococci.

MALDI-TOF MS method for differentiation of methicillin-sensitive and methicillin-resistant Staphylococcus aureus using (E)-Propyl α-cyano-4-Hydroxyl cinnamylate

A New Fusion Strategy for Rapid Strain Differentiation Based on MALDI-TOF MS and Raman Spectra.

Improvement of Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry for Identification of Clinically Important Candida Species

The Value of Matrix-Assisted Laser Desorption/ionization Time-of-flight Mass Spectrometry in Identifying Clinically Relevant Bacteria: a Comparison with Automated Microbiology System.

Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) Analysis for the Identification of Pathogenic Microorganisms: A Review

The construction and evaluation of reference spectra for the identification of human pathogenic microorganisms by MALDI-TOF MS.

MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance

Toward Spectral Library-Free Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Bacterial Identification.

Evaluation Of An In-House Maldi-Tof Ms Rapid Diagnostic Method For Direct Identification Of Micro-Organisms From Blood Cultures